Literature DB >> 27467969

Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.

Hesham R Omar1, Maya Guglin2.   

Abstract

INTRODUCTION: Prior studies found a significant relationship between admission B-type natriuretic peptide (BNP), discharge BNP and admission-to-discharge percentage BNP reduction and post-discharge mortality in acute heart failure (HF).
METHODS: The ESCAPE trial data was utilized to identify which of these BNP parameters best predicts 6-month all-cause mortality.
RESULTS: 433 patients (mean age 56years, 74% men) included in our analysis had an admission BNP, discharge BNP and admission-to-discharge percentage BNP reduction of 1009pg/mL, 743pg/mL and -70%, respectively. There were significant differences between survivors and nonsurvivors with regards to admission BNP (P=0.001), discharge BNP (P=0.0001) and admission-to-discharge percentage BNP reduction (P=0.01). Discharge BNP had the highest area under the curve (AUC) for predicting mortality (AUC=0.702, P<0.001) followed by admission BNP (AUC=0.633, P=0.0006) then percentage BNP reduction (AUC=0.620, P=0.008). Comparison of AUC revealed a significant difference between discharge BNP and admission BNP (difference between areas 0.087, P=0.0223) and a trend towards significance when comparing AUC of discharge BNP with percentage BNP reduction (P=0.0637). Kaplan-Meier analysis showed a significant difference in survival according to optimum cutoff values of discharge BNP of 319pg/mL (log-rank P<0.001), admission BNP of 912pg/mL (P<0.001) and percentage BNP reduction of 7.71% (P=0.008). Cox-proportional-hazard-analysis revealed that discharge BNP is an independent predictor of 6-month mortality (hazard ratio=1.063, 95% CI=1.037-1.089, P<0.001). The combination of a discharge BNP ≤319pg/mL and percentage BNP reduction ≥7.71% was associated with significantly lower mortality (4.8% versus 27.2%, relative risk=0.134, 95% CI=0.046-0.387, P<0.001).
CONCLUSION: The absolute BNP value at discharge is a more accurate predictor of 6-month mortality than the magnitude of percentage in-hospital BNP reduction and baseline BNP.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  B-type natriuretic peptide; Heart failure; Mortality; Rehospitalization

Mesh:

Substances:

Year:  2016        PMID: 27467969     DOI: 10.1016/j.ijcard.2016.07.117

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.

Authors:  Hidenori Moriyama; Takashi Kohno; Shun Kohsaka; Yasuyuki Shiraishi; Ryoma Fukuoka; Yuji Nagatomo; Ayumi Goda; Atsushi Mizuno; Keiichi Fukuda; Tsutomu Yoshikawa
Journal:  Heart Vessels       Date:  2019-05-27       Impact factor: 2.037

Review 2.  Current clinical applications of speckle tracking echocardiography for assessment of left atrial function.

Authors:  Satoshi Yuda
Journal:  J Echocardiogr       Date:  2021-03-09

3.  Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration.

Authors:  T Sadowski; S Dietrich; F Koschinsky; A Ludwig; E Proksch; B Titz; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2005-04       Impact factor: 9.261

Review 4.  Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC).

Authors:  Wouter C Meijers; Antoni Bayes-Genis; Alexandre Mebazaa; Johann Bauersachs; John G F Cleland; Andrew J S Coats; James L Januzzi; Alan S Maisel; Kenneth McDonald; Thomas Mueller; A Mark Richards; Petar Seferovic; Christian Mueller; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2021-10-10       Impact factor: 17.349

5.  Rise in BNP despite appropriate acute decompensated heart failure treatment : Patient characteristics and outcomes.

Authors:  H R Omar; M Guglin
Journal:  Herz       Date:  2016-09-13       Impact factor: 1.443

Review 6.  Consensus document: management of heart failure in type 2 diabetes mellitus.

Authors:  Upendra Kaul; Saumitra Ray; D Prabhakar; Arun Kochar; Kamal Sharma; Prakash Kumar Hazra; Subhash Chandra; Dharmesh Ramakant Bhai Solanki; Anjan Lal Dutta; Viveka Kumar; M Srinivas Rao; Abraham Oomman; Sameer Dani; Brian Pinto; T R Raghu
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

7.  Prognostic significance of high-sensitivity cardiac troponin in patients with heart failure with preserved ejection fraction.

Authors:  Sho Suzuki; Hirohiko Motoki; Masatoshi Minamisawa; Yukari Okuma; Wataru Shoin; Takahiro Okano; Kazuhiro Kimura; Soichiro Ebisawa; Ayako Okada; Koichiro Kuwahara
Journal:  Heart Vessels       Date:  2019-03-30       Impact factor: 2.037

8.  Stay Home! Stay Safe! First Post-Discharge Cardiologic Evaluation of Low-Risk-Low-BNP Heart Failure Patients in COVID-19 Era.

Authors:  Nadia Aspromonte; Luigi Cappannoli; Pietro Scicchitano; Francesco Massari; Ivan Pantano; Massimo Massetti; Filippo Crea; Roberto Valle
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.